Could a popular COVID-19 antiviral supercharge the pandemic?

Using nanomaterials as antivirals in the fight against COVID-19

Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations

Omicron subvariant XBB.1.5 appears to be a ‘vaccine breaker’ — New variant of the novel coronavirus now makes up more than half of U.S. COVID-19 cases, and is on track to be the country’s most dominant strain (30 Jan. 2023)